nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—SLCO1A2—Chlorambucil—ovarian cancer	0.597	0.811	CbGbCtD
Tolbutamide—CYP2C8—Paclitaxel—ovarian cancer	0.0818	0.111	CbGbCtD
Tolbutamide—CYP2C9—Paclitaxel—ovarian cancer	0.0571	0.0775	CbGbCtD
Tolbutamide—Inappropriate antidiuretic hormone secretion—Chlorambucil—ovarian cancer	0.00966	0.0435	CcSEcCtD
Tolbutamide—Pancytopenia—Altretamine—ovarian cancer	0.00941	0.0423	CcSEcCtD
Tolbutamide—Digestion impaired—Chlorambucil—ovarian cancer	0.0084	0.0378	CcSEcCtD
Tolbutamide—Inappropriate antidiuretic hormone secretion—Vinorelbine—ovarian cancer	0.00736	0.0331	CcSEcCtD
Tolbutamide—Digestion impaired—Melphalan—ovarian cancer	0.00732	0.0329	CcSEcCtD
Tolbutamide—Reaction gastrointestinal—Docetaxel—ovarian cancer	0.0073	0.0328	CcSEcCtD
Tolbutamide—Heartburn—Topotecan—ovarian cancer	0.00726	0.0327	CcSEcCtD
Tolbutamide—Leukopenia—Altretamine—ovarian cancer	0.00618	0.0278	CcSEcCtD
Tolbutamide—Thrombocytopenia—Altretamine—ovarian cancer	0.00552	0.0248	CcSEcCtD
Tolbutamide—Gliclazide—VEGFA—ovarian cancer	0.00524	0.733	CrCbGaD
Tolbutamide—Haemolytic anaemia—Chlorambucil—ovarian cancer	0.00452	0.0203	CcSEcCtD
Tolbutamide—Aplastic anaemia—Vinorelbine—ovarian cancer	0.00402	0.0181	CcSEcCtD
Tolbutamide—Eruption—Docetaxel—ovarian cancer	0.00396	0.0178	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Melphalan—ovarian cancer	0.00394	0.0177	CcSEcCtD
Tolbutamide—Hyponatraemia—Melphalan—ovarian cancer	0.00357	0.016	CcSEcCtD
Tolbutamide—Heartburn—Docetaxel—ovarian cancer	0.00354	0.0159	CcSEcCtD
Tolbutamide—Nausea—Altretamine—ovarian cancer	0.00335	0.0151	CcSEcCtD
Tolbutamide—Pancytopenia—Chlorambucil—ovarian cancer	0.00335	0.015	CcSEcCtD
Tolbutamide—Hyponatraemia—Vinorelbine—ovarian cancer	0.00312	0.014	CcSEcCtD
Tolbutamide—Pancytopenia—Topotecan—ovarian cancer	0.00298	0.0134	CcSEcCtD
Tolbutamide—Pancytopenia—Melphalan—ovarian cancer	0.00292	0.0131	CcSEcCtD
Tolbutamide—Eruption—Epirubicin—ovarian cancer	0.00267	0.012	CcSEcCtD
Tolbutamide—CYP2C18—uterine cervix—ovarian cancer	0.00267	0.0785	CbGeAlD
Tolbutamide—Pancytopenia—Vinorelbine—ovarian cancer	0.00255	0.0115	CcSEcCtD
Tolbutamide—Eruption—Doxorubicin—ovarian cancer	0.00247	0.0111	CcSEcCtD
Tolbutamide—Agranulocytosis—Vinorelbine—ovarian cancer	0.00223	0.01	CcSEcCtD
Tolbutamide—Leukopenia—Chlorambucil—ovarian cancer	0.0022	0.00988	CcSEcCtD
Tolbutamide—Hypoglycaemia—Paclitaxel—ovarian cancer	0.00214	0.00962	CcSEcCtD
Tolbutamide—Hyponatraemia—Paclitaxel—ovarian cancer	0.0021	0.00943	CcSEcCtD
Tolbutamide—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00196	0.00882	CcSEcCtD
Tolbutamide—Leukopenia—Topotecan—ovarian cancer	0.00196	0.0088	CcSEcCtD
Tolbutamide—Leukopenia—Melphalan—ovarian cancer	0.00192	0.00861	CcSEcCtD
Tolbutamide—SLC15A1—epithelium—ovarian cancer	0.0019	0.0558	CbGeAlD
Tolbutamide—Jaundice cholestatic—Epirubicin—ovarian cancer	0.00187	0.00842	CcSEcCtD
Tolbutamide—Erythema—Vinorelbine—ovarian cancer	0.00187	0.00841	CcSEcCtD
Tolbutamide—Abdominal distension—Paclitaxel—ovarian cancer	0.00182	0.00817	CcSEcCtD
Tolbutamide—CYP2C18—vagina—ovarian cancer	0.00181	0.0532	CbGeAlD
Tolbutamide—ABCC8—endometrium—ovarian cancer	0.00178	0.0523	CbGeAlD
Tolbutamide—Hyponatraemia—Docetaxel—ovarian cancer	0.00178	0.00799	CcSEcCtD
Tolbutamide—Dyspepsia—Chlorambucil—ovarian cancer	0.00176	0.00793	CcSEcCtD
Tolbutamide—Thrombocytopenia—Topotecan—ovarian cancer	0.00175	0.00785	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.00173	0.00779	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00173	0.00778	CcSEcCtD
Tolbutamide—Pancytopenia—Paclitaxel—ovarian cancer	0.00171	0.00771	CcSEcCtD
Tolbutamide—Thrombocytopenia—Melphalan—ovarian cancer	0.00171	0.00769	CcSEcCtD
Tolbutamide—SLC15A1—endometrium—ovarian cancer	0.0017	0.05	CbGeAlD
Tolbutamide—Leukopenia—Vinorelbine—ovarian cancer	0.00167	0.00753	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.00165	0.00741	CcSEcCtD
Tolbutamide—KCNJ11—female reproductive system—ovarian cancer	0.0016	0.0471	CbGeAlD
Tolbutamide—Urticaria—Chlorambucil—ovarian cancer	0.00159	0.00716	CcSEcCtD
Tolbutamide—Dyspepsia—Topotecan—ovarian cancer	0.00157	0.00706	CcSEcCtD
Tolbutamide—Aplastic anaemia—Epirubicin—ovarian cancer	0.00154	0.00694	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00154	0.00692	CcSEcCtD
Tolbutamide—Dyspepsia—Melphalan—ovarian cancer	0.00154	0.00691	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00151	0.00678	CcSEcCtD
Tolbutamide—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00149	0.00672	CcSEcCtD
Tolbutamide—SLCO2B1—decidua—ovarian cancer	0.00147	0.0431	CbGeAlD
Tolbutamide—KCNJ11—female gonad—ovarian cancer	0.00146	0.0428	CbGeAlD
Tolbutamide—Pancytopenia—Docetaxel—ovarian cancer	0.00145	0.00653	CcSEcCtD
Tolbutamide—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00143	0.00642	CcSEcCtD
Tolbutamide—Pruritus—Chlorambucil—ovarian cancer	0.00142	0.00637	CcSEcCtD
Tolbutamide—Urticaria—Topotecan—ovarian cancer	0.00142	0.00637	CcSEcCtD
Tolbutamide—Urticaria—Melphalan—ovarian cancer	0.00139	0.00624	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00132	0.00592	CcSEcCtD
Tolbutamide—SLCO2B1—uterus—ovarian cancer	0.00128	0.0377	CbGeAlD
Tolbutamide—SLC15A1—vagina—ovarian cancer	0.00128	0.0375	CbGeAlD
Tolbutamide—Agranulocytosis—Docetaxel—ovarian cancer	0.00127	0.00572	CcSEcCtD
Tolbutamide—Pruritus—Topotecan—ovarian cancer	0.00126	0.00567	CcSEcCtD
Tolbutamide—Erythema—Paclitaxel—ovarian cancer	0.00126	0.00565	CcSEcCtD
Tolbutamide—Pruritus—Melphalan—ovarian cancer	0.00124	0.00556	CcSEcCtD
Tolbutamide—Hypoglycaemia—Epirubicin—ovarian cancer	0.00122	0.0055	CcSEcCtD
Tolbutamide—Urticaria—Vinorelbine—ovarian cancer	0.00121	0.00545	CcSEcCtD
Tolbutamide—Hyponatraemia—Epirubicin—ovarian cancer	0.0012	0.00539	CcSEcCtD
Tolbutamide—ABCC8—testis—ovarian cancer	0.00119	0.035	CbGeAlD
Tolbutamide—Nausea—Chlorambucil—ovarian cancer	0.00119	0.00535	CcSEcCtD
Tolbutamide—SLC15A2—uterine cervix—ovarian cancer	0.00118	0.0346	CbGeAlD
Tolbutamide—SLCO2B1—female reproductive system—ovarian cancer	0.00115	0.0339	CbGeAlD
Tolbutamide—Hypoglycaemia—Doxorubicin—ovarian cancer	0.00113	0.00509	CcSEcCtD
Tolbutamide—Leukopenia—Paclitaxel—ovarian cancer	0.00113	0.00506	CcSEcCtD
Tolbutamide—Rash—Topotecan—ovarian cancer	0.00112	0.00506	CcSEcCtD
Tolbutamide—Headache—Topotecan—ovarian cancer	0.00112	0.00502	CcSEcCtD
Tolbutamide—Hyponatraemia—Doxorubicin—ovarian cancer	0.00111	0.00499	CcSEcCtD
Tolbutamide—Rash—Melphalan—ovarian cancer	0.0011	0.00495	CcSEcCtD
Tolbutamide—Pruritus—Vinorelbine—ovarian cancer	0.00108	0.00485	CcSEcCtD
Tolbutamide—Erythema—Docetaxel—ovarian cancer	0.00107	0.00479	CcSEcCtD
Tolbutamide—SLC15A2—endometrium—ovarian cancer	0.00106	0.0313	CbGeAlD
Tolbutamide—Nausea—Topotecan—ovarian cancer	0.00106	0.00476	CcSEcCtD
Tolbutamide—SLCO2B1—female gonad—ovarian cancer	0.00105	0.0309	CbGeAlD
Tolbutamide—Chlorpropamide—ABCB1—ovarian cancer	0.00105	0.146	CrCbGaD
Tolbutamide—Abdominal distension—Epirubicin—ovarian cancer	0.00104	0.00467	CcSEcCtD
Tolbutamide—Nausea—Melphalan—ovarian cancer	0.00104	0.00466	CcSEcCtD
Tolbutamide—Thrombocytopenia—Paclitaxel—ovarian cancer	0.001	0.00452	CcSEcCtD
Tolbutamide—Pancytopenia—Epirubicin—ovarian cancer	0.00098	0.00441	CcSEcCtD
Tolbutamide—Rash—Vinorelbine—ovarian cancer	0.000962	0.00433	CcSEcCtD
Tolbutamide—Abdominal distension—Doxorubicin—ovarian cancer	0.000961	0.00432	CcSEcCtD
Tolbutamide—Headache—Vinorelbine—ovarian cancer	0.000956	0.0043	CcSEcCtD
Tolbutamide—Leukopenia—Docetaxel—ovarian cancer	0.000954	0.00429	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000942	0.00423	CcSEcCtD
Tolbutamide—KCNJ11—lymph node—ovarian cancer	0.000937	0.0275	CbGeAlD
Tolbutamide—SLCO2B1—testis—ovarian cancer	0.000932	0.0274	CbGeAlD
Tolbutamide—Pancytopenia—Doxorubicin—ovarian cancer	0.000907	0.00408	CcSEcCtD
Tolbutamide—Nausea—Vinorelbine—ovarian cancer	0.000906	0.00408	CcSEcCtD
Tolbutamide—Dyspepsia—Paclitaxel—ovarian cancer	0.000903	0.00406	CcSEcCtD
Tolbutamide—CYP2C8—endometrium—ovarian cancer	0.000896	0.0263	CbGeAlD
Tolbutamide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000886	0.00398	CcSEcCtD
Tolbutamide—SLC15A2—female reproductive system—ovarian cancer	0.000882	0.0259	CbGeAlD
Tolbutamide—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000871	0.00392	CcSEcCtD
Tolbutamide—Probenecid—ABCB1—ovarian cancer	0.000864	0.121	CrCbGaD
Tolbutamide—Agranulocytosis—Epirubicin—ovarian cancer	0.000858	0.00386	CcSEcCtD
Tolbutamide—SLCO1A2—testis—ovarian cancer	0.000858	0.0252	CbGeAlD
Tolbutamide—Thrombocytopenia—Docetaxel—ovarian cancer	0.000852	0.00383	CcSEcCtD
Tolbutamide—Urticaria—Paclitaxel—ovarian cancer	0.000815	0.00367	CcSEcCtD
Tolbutamide—SLC15A2—female gonad—ovarian cancer	0.000802	0.0236	CbGeAlD
Tolbutamide—SLC15A2—vagina—ovarian cancer	0.000797	0.0234	CbGeAlD
Tolbutamide—Agranulocytosis—Doxorubicin—ovarian cancer	0.000794	0.00357	CcSEcCtD
Tolbutamide—CYP2C19—vagina—ovarian cancer	0.000769	0.0226	CbGeAlD
Tolbutamide—Dyspepsia—Docetaxel—ovarian cancer	0.000766	0.00344	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000751	0.00338	CcSEcCtD
Tolbutamide—CYP2C8—female reproductive system—ovarian cancer	0.000742	0.0218	CbGeAlD
Tolbutamide—Pruritus—Paclitaxel—ovarian cancer	0.000726	0.00326	CcSEcCtD
Tolbutamide—Erythema—Epirubicin—ovarian cancer	0.000719	0.00323	CcSEcCtD
Tolbutamide—SLC15A2—testis—ovarian cancer	0.000712	0.0209	CbGeAlD
Tolbutamide—SLCO2B1—lymph node—ovarian cancer	0.000675	0.0198	CbGeAlD
Tolbutamide—CYP2C8—vagina—ovarian cancer	0.000671	0.0197	CbGeAlD
Tolbutamide—Erythema—Doxorubicin—ovarian cancer	0.000665	0.00299	CcSEcCtD
Tolbutamide—CYP2C9—female reproductive system—ovarian cancer	0.000659	0.0194	CbGeAlD
Tolbutamide—Rash—Paclitaxel—ovarian cancer	0.000647	0.00291	CcSEcCtD
Tolbutamide—Leukopenia—Epirubicin—ovarian cancer	0.000643	0.00289	CcSEcCtD
Tolbutamide—Headache—Paclitaxel—ovarian cancer	0.000643	0.00289	CcSEcCtD
Tolbutamide—Pruritus—Docetaxel—ovarian cancer	0.000615	0.00277	CcSEcCtD
Tolbutamide—Nausea—Paclitaxel—ovarian cancer	0.00061	0.00274	CcSEcCtD
Tolbutamide—CYP2C8—testis—ovarian cancer	0.000599	0.0176	CbGeAlD
Tolbutamide—Leukopenia—Doxorubicin—ovarian cancer	0.000595	0.00268	CcSEcCtD
Tolbutamide—Thrombocytopenia—Epirubicin—ovarian cancer	0.000574	0.00258	CcSEcCtD
Tolbutamide—Rash—Docetaxel—ovarian cancer	0.000548	0.00247	CcSEcCtD
Tolbutamide—Headache—Docetaxel—ovarian cancer	0.000545	0.00245	CcSEcCtD
Tolbutamide—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000532	0.00239	CcSEcCtD
Tolbutamide—Nausea—Docetaxel—ovarian cancer	0.000517	0.00232	CcSEcCtD
Tolbutamide—Dyspepsia—Epirubicin—ovarian cancer	0.000516	0.00232	CcSEcCtD
Tolbutamide—SLC15A2—lymph node—ovarian cancer	0.000516	0.0152	CbGeAlD
Tolbutamide—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000507	0.00228	CcSEcCtD
Tolbutamide—Dyspepsia—Doxorubicin—ovarian cancer	0.000478	0.00215	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000469	0.00211	CcSEcCtD
Tolbutamide—Urticaria—Epirubicin—ovarian cancer	0.000466	0.0021	CcSEcCtD
Tolbutamide—Urticaria—Doxorubicin—ovarian cancer	0.000431	0.00194	CcSEcCtD
Tolbutamide—Pruritus—Epirubicin—ovarian cancer	0.000415	0.00187	CcSEcCtD
Tolbutamide—Pruritus—Doxorubicin—ovarian cancer	0.000384	0.00173	CcSEcCtD
Tolbutamide—Rash—Epirubicin—ovarian cancer	0.00037	0.00166	CcSEcCtD
Tolbutamide—Headache—Epirubicin—ovarian cancer	0.000368	0.00165	CcSEcCtD
Tolbutamide—Nausea—Epirubicin—ovarian cancer	0.000348	0.00157	CcSEcCtD
Tolbutamide—Rash—Doxorubicin—ovarian cancer	0.000342	0.00154	CcSEcCtD
Tolbutamide—Headache—Doxorubicin—ovarian cancer	0.00034	0.00153	CcSEcCtD
Tolbutamide—Nausea—Doxorubicin—ovarian cancer	0.000322	0.00145	CcSEcCtD
